載入...

Sorafenib in the management of metastatic renal cell carcinoma

PURPOSE: Sorafenib represents one of the two standards of care for patients with metastatic renal cell carcinoma (mrcc). In the present review, we provide information regarding the use of sorafenib in first and second lines. We also describe results for dose escalation strategies. Finally, we provid...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Guevremont, C., Jeldres, C., Perrotte, P., Karakiewicz, P.I.
格式: Artigo
語言:Inglês
出版: Multimed Inc. 2009
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687798/
https://ncbi.nlm.nih.gov/pubmed/19478894
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!